Anna Baramidze, MD, PhD, Todua Clinic, Tbilisi, Georgia, details exciting findings from the EMPOWER-Lung 1 trial regarding cemiplimab and patients with non–small cell lung cancer (NSCLC).

During the Delta wave of COVID-19, higher caseload strain negatively impacted patient survival rates across US hospitals, regardless of their size or resources.

Data presented in the second Presidential Symposium at the 2024 World Conference on Lung Cancer showed encouraging responses to novel agents among patients with HER2-mutated non–small cell lung cancer ...

A panel of experts examines the impact of cardiometabolic diseases in the United States, focusing on their burden, prevalence, and relationship to obesity.

Donor lymphocyte infusion, both alone and in combination with azacitidine, restored CD34 levels in two-thirds of patients ...

Speakers at the European Respiratory Society Congress 2024 provided updates to the 2 trials focusing on depemokimab for ...

Samyukta Mullangi, MD, MBA, medical director at Thyme Care, explained her excitement to meet with industry leaders, share best practices, and learn about new innovations in oncology care at ...

Research presented at the 2024 European Society of Cardiology Congress explored gender-based care and outcomes disparities, ...

September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our ...

New findings highlight the potential role of artificial intelligence (AI) in supporting health care professionals, but ...

Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester, shares findings from the FLAME trial on blood eosinophil changes in patients with chronic ...

Wanda Phipatanakul, MD, MS, professor of pediatrics at Harvard Medical School, and director of the Clinical Research Center at Boston Children's Hospital, discusses some of the most significant health ...